Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naive HIV-1 patients with acute and chronic infection

By Re M.C.   Monari P.   Bon I.   Borderi M.   Chiodo F.   HIV-1 Emilia Romagna Infectious Disease Study Group  

International Journal of Antimicrobial Agents, Vol. 23, Iss. 2, 2004-02 ,pp. : 164-168

Elsevier

Access to resources Recommend Favorite

A Comparative Study of Drug Resistance Mechanism Associated with Active Site and Non-Active Site Mutations: I388N and D425G Mutants of Acetyl-Coenzyme-A Carboxylase

By  

Current Computer - Aided Drug Design, Vol. 8, Iss. 1, 2012-03 ,pp. : 62-69

Bentham Science Publishers

Access to resources Recommend Favorite

Resistance Mutations Against HCV Protease Inhibitors and Antiviral Drug Design

By  

Current Pharmaceutical Design, Vol. 20, Iss. 5, 2014-02 ,pp. : 694-703

Bentham Science Publishers

Access to resources Recommend Favorite

Substrates and Inhibitors of Human Multidrug Resistance Associated Proteins and the Implications in Drug Development

By  

Current Medicinal Chemistry, Vol. 15, Iss. 20, 2008-08 ,pp. : 1981-2039

Bentham Science Publishers

Access to resources Recommend Favorite

Influence of Mutations in the Hepatitis B Virus Genome on Virus Replication and Drug Resistance - Implications for Novel Antiviral Strategies

By  

Current Medicinal Chemistry, Vol. 11, Iss. 20, 2004-10 ,pp. : 2667-2677

Bentham Science Publishers

Access to resources Recommend Favorite